Aspirin-Triggered Lipoxin and Resolvin E1 Modulate Vascular Smooth Muscle Phenotype and Correlate with Peripheral Atherosclerosis

Cited by (204)

Items 101–200 of 204

1. Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy
   Alexander S. Kim, Michael S. Conte · 2020 · Advanced Drug Delivery Reviews
2. Dead cell and debris clearance in the atherosclerotic plaque: Mechanisms and therapeutic opportunities to promote inflammation resolution
   Umesh Kumar Dhawan, Aarushi Singhal, Manikandan Subramanian · 2021 · Pharmacological Research
3. Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications
   Monica de Gaetano, Caitríona M. McEvoy, Darrell C. Andrews, Antonino Cacace, Jonathan Hunter, Eoin Patrick Brennan, Catherine Godson · 2018 · Frontiers in Pharmacology
4. Studies on Isoniazid Derivatives through a Medicinal Chemistry Approach for the Identification of New Inhibitors of Urease and Inflammatory Markers
   Fazila Rizvi, Majid Khan, Almas Jabeen, H.L. Siddiqui, Muhammad Iqbal Choudhary · 2019 · Scientific Reports
5. Patients with unrecognized peripheral arterial disease (PAD) assessed by ankle-brachial index (ABI) present a defined profile of proinflammatory markers compared to healthy subjects
   Salvatore Santo Signorelli, Massimiliano Anzaldi, Valerio Fiore, Massimo Simili, Giuseppe Puccia, Massimo Libra, Graziella Malaponte, Sergio Neri · 2012 · Cytokine
6. Atherothrombosis and the NLRP3 inflammasome – endogenous mechanisms of inhibition
   Mohan Satish, Devendra K. Agrawal · 2019 · Translational research
7. Aspirin enhances protective effect of fish oil against thrombosis and injury‐induced vascular remodelling
   Yanjun Gong, Minghui Lin, Lingjuan Piao, Xinzhi Li, Fei Yang, Jian Zhang, Bing Xiao, Qingli Zhang, Wen‐Liang Song, Huiyong Yin et al. · 2014 · British Journal of Pharmacology
8. Resolvin E1 Attenuates Pulmonary Hypertension by Suppressing Wnt7a/β-Catenin Signaling
   Guizhu Liu, Naifu Wan, Qian Liu, Yuqin Chen, Hui Cui, Yuanyang Wang, Jiaoqi Ren, Xia Shen, Wenju Lu, Ying Yu et al. · 2021 · Hypertension
9. The atheroprotective role of lipoxin A4 prevents oxLDL-induced apoptotic signaling in macrophages via JNK pathway
   Mai, Jingting, Liu, Wenhao, Fang, YongBiao, Zhang, Shujuan, Qiu, Qiong, Yang, Ying, Wang, Xiaoqiao, Huang, TuCheng, Zhang, HaiFeng, Xie, Yong et al. · 2018 · Atherosclerosis
10. Icosapent ethyl in cardiovascular prevention: Resolution of inflammation through the eicosapentaenoic acid - resolvin E1 - ChemR23 axis
    Magnus Bäck · 2023 · Pharmacology & Therapeutics
11. Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease
    S. Marlene Grenon, Michael S. Conte, Emily V. Nosova, Hugh F. Alley, Karen C Chong, William Stephen Harris, Eric Vittinghoff, Christopher D. Owens · 2013 · Journal of Vascular Surgery
12. Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling
    Lucía Serrano Díaz del Campo, Raquel Rodrigues‐Díez, Mercedes Salaíces, Ana María Briones, Ana B. García‐Redondo · 2022 · International Journal of Molecular Sciences
13. Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury
    Ping Yin, Yafen Wei, Xu Wang, Mingqin Zhu, Jiachun Feng · 2018 · Frontiers in Neurology
14. Sex differences in eicosanoid formation and metabolism: A possible mediator of sex discrepancies in cardiovascular diseases
    Samar H. Gerges, Ayman O.S. El‐Kadi · 2021 · Pharmacology & Therapeutics
15. microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense
    Anna Maria Pierdomenico, Sara Patruno, Marilina Codagnone, Felice Simiele, Veronica Cecilia Mari, Roberto Plebani, Antonio Recchiuti, Mario Romano · 2017 · Scientific Reports
16. Endothelium as a Therapeutic Target in Diabetes Mellitus: From Basic Mechanisms to Clinical Practice
    Anastasios Tentolouris, Ioanna Eleftheriadou, Evangelia Tzeravini, Dimitrios Tsilingiris, Stavroula Α. Paschou, Gerasimos Siasos, Nikolaοs Tentolouris · 2019 · Current Medicinal Chemistry
17. Pro-Resolving Ligands Orchestrate Phagocytosis
    Christa Decker, Sudeshna Sadhu, Gabrielle Fredman · 2021 · Frontiers in Immunology
18. Classes of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis
    Valter Lubrano, Rudina Ndreu, Silvana Balzan · 2023 · International Journal of Molecular Sciences
19. Novel Endogenous Proresolving Molecules:Essential Fatty Acid-Derived and Gaseous Mediators in the Resolution of Inflammation
    Masakazu Shinohara, Charles Nicholas Serhan · 2016 · Journal of Atherosclerosis and Thrombosis
20. n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial
    S. Marlene Grenon, Christopher D. Owens, Hugh F. Alley, Karen C Chong, Priscilla K. Yen, William Stephen Harris, Millie Hughes‐Fulford, Michael S. Conte · 2013 · Vascular Medicine
21. Opposing Effects on Vascular Smooth Muscle Cell Proliferation and Macrophage-induced Inflammation Reveal a Protective Role for the Proresolving Lipid Mediator Receptor ChemR23 in Intimal Hyperplasia
    Gonzalo Artiach, Miguel Carracedo, Joan Clària, Andrés Laguna-Fernández, Magnus Bäck · 2018 · Frontiers in Pharmacology
22. G-Protein Coupled Receptor Targeting on Myeloid Cells in Atherosclerosis
    Emiel P. C. van der Vorst, Linsey J. F. Peters, Madeleine Müller, Selin Gencer, Yi Yan, Christian Weber, Yvonne Döring · 2019 · Frontiers in Pharmacology
23. Polyunsaturated fatty acids and peripheral artery disease
    S. Marlene Grenon, Millie Hughes‐Fulford, Joseph H. Rapp, Michael S. Conte · 2012 · Vascular Medicine
24. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis
    Stanislav Nikolaevich Kotlyarov, Анна Анатольевна Котлярова · 2022 · International Journal of Molecular Sciences
25. Resolvin D2 and its receptor GPR18 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target
    Mengmeng Zhao, Zihui Zheng, Zheng Yin, Jishou Zhang, Juan‐Juan Qin, Jun Wan, Menglong Wang · 2023 · Pharmacological Research
26. Bioengineered vascular constructs as living models for in vitro cardiovascular research
    Frederic M. Wolf, Felix Vogt, Thomas Schmitz‐Rode, Stefan Jockenhoevel, Petra Mela · 2016 · Drug Discovery Today
27. Specialized pro-resolving mediators in diabetes: novel therapeutic strategies
    Eoin Patrick Brennan, Muthukumar Mohan, Darrell C. Andrews, Madhura Bose, Phillip Kantharidis · 2019 · Clinical Science
28. The potential of lipid mediator networks as ocular surface therapeutics and biomarkers
    Becca A. Flitter, Xiaohui Fang, Michael A. Matthay, Karsten Gronert · 2020 · The Ocular Surface
29. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis
    Juan José Salazar, Daniela Pírela, Manuel Nava, Ana Valéria Castro, Lissé Angarita, Heliana Parra, Samuel Durán‐Agüero, Diana Marcela Rojas-Gómez, Néstor Galbán, Roberto Áñez et al. · 2022 · International Journal of Molecular Sciences
30. Utility of the Specialized Pro-Resolving Mediators as Diagnostic and Prognostic Biomarkers in Disease
    Jesmond Dalli, Esteban A. Gómez, Charlotte Camille Jouvene · 2022 · Biomolecules
31. LncRNA SENCR overexpression attenuated the proliferation, migration and phenotypic switching of vascular smooth muscle cells in aortic dissection via the miR-206/myocardin axis
    Yi Song, Tao Wang, Chunjie Mu, Wenting Gui, Yao Liang Deng, Runwei Ma · 2022 · Nutrition Metabolism and Cardiovascular Diseases
32. Deciphering the role of n-3 polyunsaturated fatty acid-derived lipid mediators in health and disease
    Matthew R. Spite · 2013 · Proceedings of The Nutrition Society
33. Cryo-EM structure of the human chemerin receptor 1–Gi protein complex bound to the C-terminal nonapeptide of chemerin
    Junlin Wang, Geng Chen, Qiwen Liao, Wenping Lyu, Aijun Liu, Lizhe Zhu, Yang Du, Richard D. Ye · 2023 · Proceedings of the National Academy of Sciences
34. Intersecting Pathways: The Role of Metabolic Dysregulation, Gastrointestinal Microbiome, and Inflammation in Acute Ischemic Stroke Pathogenesis and Outcomes
    Jarosław Nuszkiewicz, Beata Kukulska-Pawluczuk, Katarzyna Piec, Dorian Julian Jarek, Karina Motolko, Karolina Szewczyk‐Golec, Alina Woźniak · 2024 · Journal of Clinical Medicine
35. Platelet-derived microvesicles induce calcium oscillations and promote VSMC migration via TRPV4
    Shanshan Li, Shuang Gao, Yi Chen, Han Bao, Zi-Tong Li, Qing‐Ping Yao, Ji-Ting Liu, Yingxiao Wang, Ying‐Xin Qi · 2020 · Theranostics
36. Resolution of inflammation, an active process to restore the immune microenvironment balance: A novel drug target for treating arterial hypertension
    Jishou Zhang, Siqi Liu, Wen Bo Ding, Jun Wan, Juan‐Juan Qin, Menglong Wang · 2024 · Ageing Research Reviews
37. Single-cell analysis of chromatin and expression reveals age- and sex-associated alterations in the human heart
    David Fraser Read, Gregory T. Booth, Riza M. Daza, Dana L. Jackson, Rula Green Gladden, Sanjay R Srivatsan, Brent Ewing, Jennifer M. Franks, Cailyn H. Spurrell, Anne Roshella Gomes et al. · 2024 · Communications Biology
38. Chemerin Stimulates Vascular Smooth Muscle Cell Proliferation and Carotid Neointimal Hyperplasia by Activating Mitogen-Activated Protein Kinase Signaling
    Wei Guo Xiong, Yu Luo, Lin Wu, Feng Liu, Huadong Liu, Jianghua Li, Bihong Liao, Shaohong Dong · 2016 · PLoS ONE
39. Protein kinase B/AKT mediates insulin‐like growth factor 1‐induced phosphorylation and nuclear export of histone deacetylase 5 via NADPH oxidase 4 activation in vascular smooth muscle cells
    Paulina Pietruczuk, Ashish Jain, Estelle R. Simo‐Cheyou, Madhu B. Anand‐Srivastava, Ashok K. Srivastava · 2019 · Journal of Cellular Physiology
40. Specialized Pro-resolving Mediators Directs Cardiac Healing and Repair with Activation of Inflammation and Resolution Program in Heart Failure
    Ganesh V. Halade, Bochra Tourki · 2019 · Advances in experimental medicine and biology
41. Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil?
    Martin D. Rosenthal, Jayshil J. Patel, Kyle M. Staton, Robert G. Martindale, Frederick Alan Moore, Gilbert R. Upchurch · 2018 · Current Gastroenterology Reports
42. Chemerin/ChemR23 signaling axis is involved in the endothelial protection by KATP channel opener iptakalim
    Ruijun Zhao, Hai Wang · 2011 · Acta Pharmacologica Sinica
43. Omega-3 (n-3) Fatty Acid–Statin Interaction: Evidence for a Novel Therapeutic Strategy for Atherosclerotic Cardiovascular Disease
    Ivana D. Djuricic, Philip C. Calder · 2024 · Nutrients
44. Prognostic impacts of Lipoxin A4 in patients with acute myocardial infarction: A prospective cohort study
    Runzhen Chen, Jiannan Li, Jinying Zhou, Ying Wang, Xiaoxiao Zhao, Nan Li, Weida Liu, Chen Liu, Peng Zhou, Yi Chen et al. · 2022 · Pharmacological Research
45. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators
    Nusrath Yasmeen, Harikrishnan Selvaraj, Sudarshan Singh Lakhawat, Manali Datta, Pushpender Kumar Sharma, Ajay Jain, Rakhi Khanna, J Srinivasan, Vikram Kumar · 2023 · Biochemical Pharmacology
46. The lipid paradox in neuroprogressive disorders: Causes and consequences
    Morris, Gerwyn, Berk, Michael, Walder, Ken, O’Neil, Adrienne, Maes, Michael, Puri, Basant K. · 2021 · Neuroscience & Biobehavioral Reviews
47. Statins and other agents for vascular inflammation
    Christopher D. Owens · 2012 · Journal of Vascular Surgery
48. Is there a role for specialized pro-resolving mediators in pulmonary fibrosis?
    Thomas H. Thatcher, M.A.T. Freeberg, Y.P.A. Myo, Patricia J. Sime · 2023 · Pharmacology & Therapeutics
49. Is Lipid Metabolism of Value in Cancer Research and Treatment? Part II: Role of Specialized Pro-Resolving Mediators in Inflammation, Infections, and Cancer
    Muhammad Usman Babar, Ala F. Nassar, Xinxin Nie, Tianxiang Zhang, Jianwei He, Jacky T. Yeung, Paul C. Norris, Hideki Ogura, Anne Muldoon, Lieping Chen et al. · 2024 · Metabolites
50. Microvesicles Derived from Inflammation-Challenged Endothelial Cells Modulate Vascular Smooth Muscle Cell Functions
    Qunwen Pan, Hua Liu, Chunyan Zheng, Yuhui Zhao, Xiaorong Liao, Yan Wang, Yanfang Chen, Bin Zhao, Eric D. Lazartigues, Yi Yang et al. · 2017 · Frontiers in Physiology
51. Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases
    Mohan Satish, Devendra K. Agrawal · 2018 · Expert Review of Cardiovascular Therapy
52. Receptors for pro-resolving mediators as a therapeutic tool for smooth muscle remodeling-associated disorders
    Gregory Livshits, Alexander Kalinkovich · 2020 · Pharmacological Research
53. Similar distribution of orally administered eicosapentaenoic acid and M2 macrophage marker in the hypoperfusion-induced abdominal aortic aneurysm wall
    Rena Fujishima, Hirona Kugo, Kenichi Yanagimoto, Hirofumi Enomoto, Tatsuya Moriyama, Nobuhiro Zaima · 2021 · Food & Function
54. Lipoxins and their relationship with inflammation-associated diseases. A systematic review
    Maria Fernanda Serna-Orozco, Mildrey Mosquera, Herney Andrés García‐Perdomo · 2023 · Obesity Research & Clinical Practice
55. Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease
    Matthew R. Spite, Gabrielle Fredman · 2023 · Advances in pharmacology
56. 17R/S-Benzo-RvD1, a synthetic resolvin D1 analogue, attenuates neointimal hyperplasia in a rat model of acute vascular injury
    Alexander S. Kim, Evan C. Werlin, Hideo Kagaya, Mian Chen, Bian Wu, Giorgio Mottola, Masood Jan, Michael S. Conte · 2022 · PLoS ONE
57. Imbalanced serum levels of resolvin E1 (RvE1) and leukotriene B4 (LTB4) may contribute to the pathogenesis of atherosclerosis
    Mohsen Molaie, Ramin Lotfi, Reza Heidari Moghadam, Alireza Rezaiemanesh, Ali Gorgin Karaji, Farhad Salari · 2023 · Prostaglandins & Other Lipid Mediators
58. rs10719 Polymorphism Located within DROSHA 3’-Untranslated Region is Responsible for Development of Primary Hypertension by Disrupting Binding with microRNA-27b
    Yabing Zhang, Ailin Cao, Chun Lan Dong · 2017 · Medical Science Monitor
59. Lipoxin A4 promotes ABCA1 expression and cholesterol efflux through the LXRα signaling pathway in THP-1 macrophage-derived foam cells.
    Yan-Hua Sha, Yan‐Wei Hu, Ji-Juan Gao, Yanchao Wang, Xin Ma, Yu‐Rong Qiu, Shufen Li, Jiayi Zhao, Chuan Huang, Jingjing Zhao et al. · 2015 · Europe PMC (PubMed Central)
60. Resolvin D1 attenuates Ang II-induced hypertension in mice by inhibiting the proliferation, migration and phenotypic transformation of vascular smooth muscle cells by blocking the RhoA/mitogen-activated protein kinase pathway
    Wei Cheng, Jishou Zhang, Shanshan Peng, Jianfang Liu, Yao Qun Xu, Mengmeng Zhao, Shuwan Xu, Wei Dong Pan, Zheng Yin, Zihui Zheng et al. · 2023 · Journal of Hypertension
61. Peripheral Artery Disease Is Associated with a Deficiency of Erythrocyte Membrane n‐3 Polyunsaturated Fatty Acids
    Joel L. Ramirez, Greg J. Zahner, Kimberly A. Spaulding, Sukaynah A. Khetani, Nancy K. Hills, Warren J. Gasper, William Stephen Harris, Beth Ellen Cohen, S. Marlene Grenon · 2019 · Lipids
62. Proresolving Lipid Mediators Restore Balance to the Vulnerable Plaque
    Edward Benjamin Thorp · 2016 · Circulation Research
63. Stimulation of non-neuronal muscarinic receptors enhances chemerin/ChemR23 system in dysfunctional endothelial cells
    Rui-Jun Zhao, Zhi-Yuan Pan, Chao-Liang Long, Wenyu Cui, Yanfang Zhang, Hai Wang · 2012 · Life Sciences
64. Effects of Omega-3 Polyunsaturated Fatty Acids on the Formation of Adipokines, Cytokines, and Oxylipins in Retroperitoneal Adipose Tissue of Mice
    Tatjana Wenderoth, Martin Feldotto, Jessica Hernandez, Julia Schäffer, Stephan Leisengang, Fabian Johannes Pflieger, Janne Bredehöft, Konstantin Mayer, Jing Xuan Kang, Jens Bier et al. · 2024 · International Journal of Molecular Sciences
65. Decreased plasma lipoxin A4, resolvin D1, protectin D1 are correlated with the complexity and prognosis of coronary heart disease: A retrospective cohort study
    Yunfei Wang, Xue-tao Zhu, Ze-ping Hu · 2025 · Prostaglandins & Other Lipid Mediators
66. Host-directed therapy for tuberculosis: Repurposed drugs toward global tuberculosis elimination
    Yi Hao Wong, Hai Tarng Chong, Ting Huey Hu, CN Ong · 2026 · International Journal of Infectious Diseases
67. Skeletal muscle expression of adipose-specific phospholipase in peripheral artery disease
    Caitlin M. Parmer, Ana Luísa De Sousa‐Coelho, Henry S. Cheng, Grace Daher, Alison Burkart, Jonathan M. Dreyfuss, Hui Pan, Joshua C. Prenner, Jessica Millian Keilson, Reena L. Pande et al. · 2020 · Vascular Medicine
68. Structural Basis for Chemerin Recognition and Signaling Through Its Receptors
    Yezhou Liu, Aijun Liu, Richard D. Ye · 2024 · Biomedicines
69. Anti-Inflammatory Lipid Mediators from Polyunsaturated Fatty Acids: Insights into their Role in Atherosclerosis Microenvironments
    Hong‐Qin Wang, Yuan Li, Lei Zhang, Mengkai Lü, Chao Li, Yunlun Li · 2025 · Current Atherosclerosis Reports
70. Lipid Signatures of Unstable Atheromas
    Matthew R. Spite, Charles Nicholas Serhan · 2011 · Circulation Cardiovascular Genetics
71. Lipoxins, Resolvins, and the Resolution of Inflammation
    Antonio Recchiuti, Eleonora Cianci, Felice Simiele, Mario Romano · 2016 · Springer eBooks
72. Dynamic changes in proresolving lipid mediators and their receptors following acute vascular injury in male rats
    Hideo Kagaya, Alexander S. Kim, Mian Chen, Pei‐Yu Lin, Xuanzhi Yin, Matthew R. Spite, Michael S. Conte · 2024 · Physiological Reports
73. Omega-3 long-chain polyunsaturated fatty acids and their bioactive lipids: A strategy to improve resistance to respiratory tract infectious diseases in the elderly?
    Kéziah Korpak, Maxime Rossi, Alain VAN MEERHAEGHE, Karim Zouaoui Boudjeltia, Michèle Compagnie · 2024 · Nutrition and Healthy Aging
74. Resolving factors of inflammation—a bridge between Innate immunity and Adaptive immunity
    Hirahito Endo · 2013 · Japanese Journal of Clinical Immunology
75. Macrophages and the Entrance of Resolution Phase Lipid Mediators
    Charles Nicholas Serhan, Nan Chiang, Jesmond Dalli · 2014 · Springer eBooks
76. Platelet inhibition by low-dose aspirin is not influenced by body mass or weight
    Sean P. Heffron, Joseph Windheim, Tessa J. Barrett, Deepak Voora, Jeffrey S. Berger · 2022 · Platelets
77. Biologically Active Lipids in Vascular Biology
    Clint M. Upchurch, Norbert Leitinger · 2019 · Learning materials in biosciences
78. The role of lipoxins in cardiometabolic physiology and disease
    Emma Börgeson · 2015 · Cardiovascular Endocrinology
79. Resolvin E1 for reducing vascular calcification
    Neil A. MacRitchie, Pasquale Maffia · 2019 · Cardiovascular Research
80. Resolution to Inflammation: Its Role in Reducing Fibrosis and Tissue Repair
    Anna Meiliana, Andi Wijaya · 2023 · The Indonesian Biomedical Journal
81. Metabolomic Characterization of Fatty Acids in Patients With Coronary Artery Ectasias
    Tianlong Liu, Yingying Sun, Hao Li, Haochen Xu, Ning Xiao, Xuliang Wang, Song Li, Congxia Bai, Hongyan Wen, Jing Ge et al. · 2021 · Frontiers in Physiology
82. Anti-inflammatory and Atheroprotective Properties of Omega-3 Polyunsaturated Fatty Acids
    Alexander V. Sorokin, Zhi Hong Yang, Alan Thomas Remaley · 2016 · Journal of Clinical & Experimental Cardiology
83. A randomized, placebo-controlled crossover trial to assess the influence of body weight on aspirin-triggered specialized pro-resolving mediators: protocol for the discover study
    Natalie G. McGowan, Judy H. Zhong, Leonardo Trasande, Jason L. Hellmann, Sean P. Heffron · 2024 · International Journal of Clinical Trials
84. Lipoxygenases and Cardiovascular Diseases
    Andrés Laguna-Fernández, Marcelo H. Petri, Silke Thul, Magnus Bäck · 2016 · Springer eBooks
85. Roles of Specialized Proresolving Lipid Mediators in Inflammation Resolution and Tissue Repair
    Matthew R. Spite, Charles Nicholas Serhan · 2017 · Wiley-VCH eBooks
86. The unbalance of adiponectin oligomers, RvE1 and chemerin levels are associate with increase of adiposopathy status and insulin resistance in obesity
    Perla-Monserrat Madrigal-Ruíz, F. Corona-Meraz, Petri MH, Mónica Vázquez-Del Mercado, Milton-Omar Guzmán-Ornelas, Griselda Guadalupe Macías-López, G-I Diaz-Rubio, Rosa Elena Navarro-Hernández · 2020 · Journal of Translational Science
87. ApoE-Knockout Mice: What are New Achievements of this Model of Atherosclerosis?
    Barbara Lorkowska-Zawicka, Jacek Jawień · 2021 · Acta Scientific Pharmaceutical Sciences
88. n-3 polyunsaturated fatty acids to heal the broken heart
    S. Marlene Grenon, Michael S. Conte · 2013 · Clinical Lipidology
89. Acute Inflammation: A Protective Host Response that May Turn into Harm
    Antonio Recchiuti · 2014
90. The role of FPR2/ALX in the vascular wall
    Marcelo H. Petri · 2015 · Figshare
91. The role of syndecan-1 in the resolution of chronic inflammatory responses
    Julianty Angsana · 2013 · SMARTech Repository (Georgia Institute of Technology)
92. Anti-atherogenic actions of dihomo-gamma-linolenic acid in macrophages
    Hayley Gallagher · 2016 · ORCA Online Research @Cardiff (Cardiff University)
93. Los niveles de mediadores prorresolutivos no corresponden con los de mediadores inflamatorios en enfermedades isquémicas coronarias
    Rashidi Springall del Villar, Jorge Arturo Ortega-Hernandez, Luis Fernando Pérez, Fausto Sánchez‐Muñoz, Julio César Arana Martínez, Héctor González‐Pacheco, Rafael Bojalil · 2018 · Gaceta Médica de México
94. Papel do microRNA-146a e seu gene alvo vasorina no remodelamento da artéria carótida após lesão por cateter balão: efeito terapêutico do treinamento físico aeróbico
    Noemy Pinto Pereira · 2020
95. Lipoxin Alleviates Diabetic Vascular Calcification via the YAP Pathway
    Baihe Han, Mengyue Yang, Qi Liu, Gang Wang, Xiaoxue Ma, Dandan Liu, Xingtao Huang, Xuedong Wang, Ruoxi Zhang, Jingbo Hou et al. · 2021 · Research Square
96. Molecular mechanisms
    Claudia Gianini Monaco, Giuseppina Caligiuri · 2017 · Oxford University Press eBooks
97. A novel protective role of lipoxin in inhibiting diabetic vascular calcification via YAP signalling: Health prevention and regulation
    Baihe Han, Mengyue Yang, Qi Liu, Gang Wang, Xiaoxue Ma, Dandan Liu, Xingtao Huang, Xuedong Wang, Ruoxi Zhang, Jingbo Hou et al. · 2023 · Preventive Medicine
98. Biologically Active Lipids in Vascular Biology
    Clint M. Upchurch, Norbert Leitinger · 2024 · Learning materials in biosciences
99. Utilization of lipoxins and other specialised pro-resolving mediators in the prevention and treatment of diabetic nephropathy and diabetic cardiovascular disease
    Ivan Bergo, Ylenia Pastorello · 2024 · Acta Marisiensis. Seria Medica
100. Impacts of Oxylipins on ischemic stroke: from pathophysiology to clinical phenotypes
     Liuyang Cheng, Jian Xia · 2025 · Metabolomics